- $482.41m
- $468.67m
- $558.27m
- 97
- 73
- 94
- 99
Annual income statement for IBEX, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
R2021 June 30th | R2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 443 | 493 | 523 | 509 | 558 |
| Cost of Revenue | |||||
| Gross Profit | 108 | 150 | 181 | 201 | 173 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 426 | 472 | 483 | 469 | 512 |
| Operating Profit | 17 | 20.6 | 40.5 | 39.4 | 46.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 15.2 | 19.4 | 40.3 | 41 | 45.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 13.1 | 21.5 | 31.6 | 33.7 | 36.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 13.1 | 21.5 | 31.6 | 33.7 | 36.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 13.1 | 21.5 | 31.6 | 33.7 | 36.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.16 | 1.26 | 1.76 | 1.98 | 2.45 |